{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:11:51Z","timestamp":1787069511969,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":3591,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1111\/j.1600-6143.2012.04341.x","type":"journal-article","created":{"date-parts":[[2012,12,27]],"date-time":"2012-12-27T16:08:36Z","timestamp":1356624516000},"page":"312-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Belatacept and Sirolimus Prolong Nonhuman Primate Islet Allograft Survival: Adverse Consequences of Concomitant Alefacept Therapy"],"prefix":"10.1016","volume":"13","author":[{"given":"M.C.","family":"Lowe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.R.","family":"Badell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.W.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.V.","family":"Leopardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.A.","family":"Strobert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.P.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2012.04341.x_bib1","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1600-6143.2003.00351.x","article-title":"Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody","volume":"4","author":"Hering","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04341.x_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04341.x_bib3","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/j.1600-6143.2010.03212.x","article-title":"Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation","volume":"10","author":"Turgeon","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04341.x_bib4","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/jama.293.7.830","article-title":"Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes","volume":"293","author":"Hering","year":"2005","journal-title":"JAMA"},{"key":"10.1111\/j.1600-6143.2012.04341.x_bib5","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/TP.0b013e31819025e5","article-title":"Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes","volume":"86","author":"Froud","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04341.x_bib6","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/j.1600-6143.2011.03724.x","article-title":"Late cytomegalovirus transmission and impact of T-depletion in clinical islet transplantation","volume":"11","author":"Gala-Lopez","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04341.x_bib7","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/TP.0b013e3181ff87cd","article-title":"Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies","volume":"90","author":"Larsen","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04341.x_bib8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04341.x_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-6143.2011.03785.x","article-title":"Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients","volume":"12","author":"Vincenti","year":"2012","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1111\/j.1600-6143.2012.04341.x_bib10","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/nm.1993","article-title":"Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates","volume":"15","author":"Weaver","year":"2009","journal-title":"Nat Med"},{"key":"10.1111\/j.1600-6143.2012.04341.x_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2337\/diabetes.51.2.265","article-title":"Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates","volume":"51","author":"Adams","year":"2002","journal-title":"Diabetes"},{"key":"10.1111\/j.1600-6143.2012.04341.x_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-6143.2010.03317.x","article-title":"Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression","volume":"11","author":"Lo","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04341.x_bib13","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.4049\/jimmunol.140.5.1401","article-title":"Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production","volume":"140","author":"Sanders","year":"1988","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2012.04341.x_bib14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM200107263450403","article-title":"Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes","volume":"345","author":"Ellis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04341.x_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2249.2007.03380.x","article-title":"Changes in circulating lymphocyte subpopulations following administration of the leucocyte function-associated antigen-3 (LFA-3)\/IgG1 fusion protein alefacept","volume":"149","author":"Larsen","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1600-6143.2012.04341.x_bib16","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1172\/JCI43895","article-title":"LFA-1-specific therapy prolongs allograft survival in rhesus macaques","volume":"120","author":"Badell","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1600-6143.2012.04341.x_bib17","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI200317477","article-title":"Heterologous immunity provides a potent barrier to transplantation tolerance","volume":"111","author":"Adams","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1600-6143.2012.04341.x_bib18","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood-2009-07-234906","article-title":"Allo-HLA reactivity of virus-specific memory T cells is common","volume":"115","author":"Amir","year":"2010","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2012.04341.x_bib19","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.4049\/jimmunol.170.8.4077","article-title":"Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections","volume":"170","author":"Brehm","year":"2003","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2012.04341.x_bib20","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3727\/096368910X545077","article-title":"Effects of acute cytomegalovirus infection on rat islet allograft survival","volume":"20","author":"Smelt","year":"2011","journal-title":"Cell transplantation"},{"issue":"Suppl 2","key":"10.1111\/j.1600-6143.2012.04341.x_bib21","first-page":"190","article-title":"A phase 2 study to assess the safety and efficacy of Alefacept (ALEF) in de novo kidney transplant recipients","volume":"11","author":"Bromberg","year":"2011","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2012.04341.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522258043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522258043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2012.04341.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:58:57Z","timestamp":1761627537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522258043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1600613522258043"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04341.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Belatacept and Sirolimus Prolong Nonhuman Primate Islet Allograft Survival: Adverse Consequences of Concomitant Alefacept Therapy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04341.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}